Letter to Representatives

The Physician Clinical Registry Coalition (“PCRC”) recently provided comments to Congress regarding the Centers for Medicare and Medicaid Services’ (“CMS”) implementation of the Medicare Access and CHIP Reauthorization Act of 2015 (“MACRA”) as it relates to Qualified Clinical Data Registries (“QCDRs”) and clinician-led clinical data registries. PCRC expressed concerns regarding current CMS policies on measure testing, data validation, measure harmonization, topped out measures, cost measures, the MIPS Value Pathway framework, and the lack of meaningful access to Medicare claims data. PCRC requested legislative intervention to ensure that CMS is properly implementing the plain language and intent of MACRA. PCRC also expressed appreciation for the inclusion of language in the bipartisan legislation-H.R. 5394, the Meaningful Access to Federal Health Plan Claims Data Act-that would help address CMS’s failure to provide QCDR’s and clinician-led clinical data registries with meaningful access to federal claims data for research and quality improvement purposes.

Click here to read the letter to Representatives Bera, Bucshon, Schrier, Burgess, Blumenauer, Wenstrup, Schneider, and Miller-Meeks.

PCRC Handout on QCDR Access to Medicare Claims Data

The Physician Registry Coalition prepared a handout on Qualified Clinical Data Registry (QCDR) access to Medicare claims data.  Neither the ResDAC process nor quasi-qualified entity program provides QCDRs with the type of access to Medicare claims data that satisfies the requirements to provide such data to QCDRs under Section 105 (b) of the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA).   Access to Medicare claims data is crucial to measuring quality improvement for QCDRs.  Therefore, the Coalition requests additional rulemaking separate from the ResDAC process and quasi-qualified entity status to provide QCDR the necessary access to Medicare claims data.

A PDF version of the handout can be viewed here.